AR032519A1 - Compuestos - Google Patents
CompuestosInfo
- Publication number
- AR032519A1 AR032519A1 ARP020100273A ARP020100273A AR032519A1 AR 032519 A1 AR032519 A1 AR 032519A1 AR P020100273 A ARP020100273 A AR P020100273A AR P020100273 A ARP020100273 A AR P020100273A AR 032519 A1 AR032519 A1 AR 032519A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- relates
- present
- methylbenzylamino
- imidazo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100296A SE0100296D0 (sv) | 2001-02-01 | 2001-02-01 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR032519A1 true AR032519A1 (es) | 2003-11-12 |
Family
ID=20282798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020100273A AR032519A1 (es) | 2001-02-01 | 2002-01-25 | Compuestos |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR032519A1 (sv) |
SE (1) | SE0100296D0 (sv) |
WO (1) | WO2002060441A1 (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1565465A1 (en) | 2002-11-19 | 2005-08-24 | ALTANA Pharma AG | 8-substituted imidazopyridines |
CA2544325A1 (en) | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
SE0303451D0 (sv) * | 2003-12-18 | 2003-12-18 | Astrazeneca Ab | New compounds |
WO2007043939A1 (en) * | 2005-10-07 | 2007-04-19 | Astrazeneca Ab | Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
-
2001
- 2001-02-01 SE SE0100296A patent/SE0100296D0/sv unknown
-
2002
- 2002-01-25 AR ARP020100273A patent/AR032519A1/es unknown
- 2002-01-30 WO PCT/SE2002/000163 patent/WO2002060441A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002060441A1 (en) | 2002-08-08 |
SE0100296D0 (sv) | 2001-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088413A (es) | Preparación y uso de derivados de tetrahidropirrolo[3,2-c]piridin-4-ona para el tratamiento de la obesidad, trastornos psiquiátricos y neurológicos | |
HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
UY28376A1 (es) | Agentes terapéuticos | |
UY27740A1 (es) | Nuevos compuestos | |
WO2006107771A3 (en) | PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS | |
CL2003002287A1 (es) | COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS | |
AR052447A1 (es) | Etansulfonato de 1-(2-metipropil)-1h-imidazo[4,5-c] [1,5] naftiridin-4- amina y metansulfonato de 1-(2- metipropil)-1h-imidazo[4,5 -c] [1,5] naftiridin-4-amina | |
UY28510A1 (es) | Compuestos quimicos | |
AR048912A1 (es) | Inmunoglobulinas anti-nogo | |
CR6726A (es) | Compuestos azapoliciclicos condensados con arilo | |
UY29781A1 (es) | Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos | |
CR9834A (es) | [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la ezquizofrenia | |
WO2006107853A3 (en) | Pyrazolopyridine-1,4-diamines and analogs thereof | |
AR054122A1 (es) | Pirido[2,3-d]pirimidas utiles como inhibidores de hcv, y metodos para la preparacion de las mismas | |
HN2002000154A (es) | Azaindoles | |
CY1113047T1 (el) | Νεα κρυσταλλικη και αμορφη μορφη μιας ενωσης τριαζολο (4,5-d) πυριμιδινης | |
EA200700144A1 (ru) | Производные пиридопиримидина, их получение, их применение в терапии | |
EA200801327A1 (ru) | Новый способ и композиции | |
HUP0402270A2 (hu) | [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények | |
CR9643A (es) | Derivados de n-(arilalquil)-1h-pirrolopiridina-2-carboxamidas, su preparacion y su aplicacion en terapeutica | |
AR028250A1 (es) | Imidazo [1,5-a]-pirido [3,2-e]-pirazinonas, la utilizacion de dichos compuestos y sus sales para la preparacion de medicamentos y los medicamentos asi preparados | |
HN2002000365A (es) | Lactamas como antagonistas de taquiquininas | |
GT200500340A (es) | Derivados de octahidropirrolo [3,4-c] pirrol | |
UY28377A1 (es) | Agentes terapeuticos | |
SI1869038T1 (sl) | Substituirane 5,6,7,8-tetrahidro-imidazo(1,2-a)piridin-2-ilaminske spojine in njihova uporaba za pripravo zdravil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |